Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vytorin vs Atorvastatin in hypercholesterolemic patients with diabetes or metabolic syndrome
NCT00157924Phase 4Completed
- Sponsor
- Organon & Co.
- Start
- Nov 2005
- Primary completion
- Sep 2007
- Modality
- Implantable Devices, Transdermal Patches, Inhalation Devices
01
Overview
Phase 4, randomised, open-label trial of Vytorin in hypercholesterolemia (2 arms), sponsored by Organon & Co. Primary endpoint: Low-Density Lipoprotein Cholesterol at 6 weeks. Started Nov 2005; status: completed.
02
Drugs
Vytorin
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on NCT00157924.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00157924.